OpenVSafe by OpenVAERS
Search V-safe

7ZV-19762-07653

5 vaccinations 10 coded responses 35 check-ins 9 free-text entries 4 call cases
Sex
Female
Age at first dose
66+
ZIP prefix
024 / MA
Registered
2021-03-20
Relationship
Self
Race
White
Ethnicity
Hispanic or Latino

Timeline

  1. 2021-02-19
    Dose 1 — Moderna
  2. 2021-03-19
    Dose 2 — Moderna
  3. 2021-03-20
    Registered in v-safe
  4. 2021-03-20
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Fever · Headache, Joint pains, Abdominal pain · Be unable to do your normal daily activities
    Adult check-in
  5. 2021-03-21
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Headache, Abdominal pain
    Adult check-in
  6. 2021-03-22
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  7. 2021-03-23
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  8. 2021-04-04
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  9. 2021-04-09
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  10. 2021-04-16
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  11. 2021-04-23
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  12. 2021-04-30
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  13. 2021-06-20
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  14. 2021-09-18
    Dose 3 — Moderna
  15. 2021-09-19
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-09-19
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain · Fever · Joint pains · Be unable to work or attend school, Be unable to do your normal daily activities
    Adult check-in
  17. 2021-09-24
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Redness, Itching · None
    Adult check-in
  18. 2021-09-28
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  19. 2021-10-02
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  20. 2021-10-11
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  21. 2021-12-19
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  22. 2022-03-19
    Survey response — 6 months, dose 3
    MedDRA: Oedema peripheral, Pruritus, Urticaria — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: utticaria rash, generalized itching and edemas more prominent in both ankles
    MedDRA releases: 2024-11 · check-in free text available
  23. 2022-03-19
    Report sent to call center — 6 months, dose 3
    Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
  24. 2022-03-22
    Call successful
    Does not wish to fill out VAERS report
  25. 2022-04-03
    Dose 4 — Moderna
  26. 2022-04-05
    Health check-in — days 1–6 daily, dose 4
    Feeling: Fair · Site: Pain · Fever · None
    Adult check-in
  27. 2022-04-08
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  28. 2022-04-17
    Health check-in — day 14, dose 4
    Feeling: Good
    Adult check-in
  29. 2022-04-24
    Health check-in — day 21, dose 4
    Feeling: Good
    Adult check-in
  30. 2022-05-03
    Survey response — day 28, dose 4
    MedDRA: Antinuclear antibody positive, Light chain analysis increased — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Diagnosed with positive antinuclear antibodies and increase free light chains kappa/lambda ratio
    MedDRA releases: 2024-11 · check-in free text available
  31. 2022-05-03
    Report sent to call center — day 28, dose 4
    Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  32. 2022-05-04
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
  33. 2022-05-10
    Health check-in — day 35, dose 4
    Feeling: Good
    Adult check-in
  34. 2022-05-15
    Health check-in — day 42, dose 4
    Feeling: Good
    Adult check-in
  35. 2022-07-03
    Health check-in — 3 months, dose 4
    Feeling: Good
    Adult check-in
  36. 2022-09-09
    Dose 5 — Moderna
  37. 2022-09-12
    Survey response — days 1–6 daily, dose 5
    MedDRA: Headache, Pyrexia, Rash, Skin oedema, Visual field defect — Feeling: Fair · Site: Redness, Swelling, Itching · Rash, not including the immediate area around the injection site · Be unable to do your normal daily activities
    Free text: generalized rash more prominent in upper arms and my face and also skin edema with fovea that blanches under pressure. Started yesterday -48 h post vaccination with bivalent vaccine. Mild fever and headaches 24 h post-vaccination. pr
    MedDRA releases: 2024-11 · check-in free text available
  38. 2022-09-13
    Survey response — days 1–6 daily, dose 5
    MedDRA: Adverse reaction, Medical counselling, Rash, Self-medication — Feeling: Good · Site: Pain, Redness, Swelling, Itching · Rash, not including the immediate area around the injection site · Get care from a doctor or other healthcare professional
    Free text: Systemic reaction (other): Taking daily 190 mg allegra due to previously reported symptoms including rash · Healthcare visit (other): Notification to allergist and primary care. Tried reporting to Moderna but no one to take the xall
    MedDRA releases: 2024-11 · check-in free text available
  39. 2022-09-13
    Report sent to call center — days 1–6 daily, dose 5
    Get care from a doctor or other healthcare professional
    1 call case(s)
  40. 2022-09-14
    Call successful
    Reported to VAERS voluntarily prior to GDIT contact
  41. 2022-09-18
    Survey response — day 7, dose 5
    MedDRA: Injection site erythema, Injection site pain, Injection site swelling, Pruritus, Rash, Swelling — Feeling: Good · Site: Redness, Itching · Rash, not including the immediate area around the injection site · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Taking fexofenadine daily sue to rash, itching, swelling. Much milderBut not gone yet. Reaction at injection sute still visible , pain, swelling, redness
    MedDRA releases: 2024-11 · check-in free text available
  42. 2022-09-18
    Report sent to call center — day 7, dose 5
    Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  43. 2022-09-20
    Call successful
    Reported to VAERS voluntarily prior to GDIT contact
  44. 2022-09-23
    Health check-in — day 14, dose 5
    Feeling: Good
    Adult check-in
  45. 2022-10-02
    Survey response — day 21, dose 5
    MedDRA: Arthralgia, Fatigue — Feeling: Fair
    Free text: Joints aches and fatigue
    MedDRA releases: 2024-11 · check-in free text available
  46. 2022-10-09
    Survey response — day 28, dose 5
    MedDRA: Arthralgia, Injection site pain — Feeling: Fair
    Free text: Joints pau. And pain in upper arm muscke ( vaccination site)
    MedDRA releases: 2024-11 · check-in free text available
  47. 2022-10-17
    Survey response — day 35, dose 5
    MedDRA: Arthralgia — Feeling: Fair
    Free text: Joints paun
    MedDRA releases: 2024-11 · check-in free text available
  48. 2022-10-23
    Survey response — day 42, dose 5
    MedDRA: Arthralgia — Feeling: Fair
    Free text: Arhtralgias
    MedDRA releases: 2024-11 · check-in free text available
  49. 2023-03-10
    Survey response — 6 months, dose 5
    MedDRA: Injection site pain, Irritable bowel syndrome, Joint instability, Muscular weakness — Feeling: Good · Be unable to do your normal daily activities
    MedDRA releases: 2024-11

Vaccinations

DoseDateManufacturerCo-administered
12021-02-19Moderna
22021-03-19Moderna
32021-09-18Moderna No
42022-04-03Moderna No
52022-09-09Moderna No

Call center

4 call center cases

4 successful

VAERS report filed, before or during a call: 2

See the call center timeline

Free text

Release 11 — 6 months, dose 3

2022-03-19

Symptoms: utticaria rash, generalized itching and edemas more prominent in both ankles

Release 11 — day 28, dose 4

2022-05-03

Symptoms: Diagnosed with positive antinuclear antibodies and increase free light chains kappa/lambda ratio

Release 12 — days 1–6 daily, dose 5

2022-09-12

Systemic reaction (other): generalized rash more prominent in upper arms and my face and also skin edema with fovea that blanches under pressure. Started yesterday -48 h post vaccination with bivalent vaccine. Mild fever and headaches 24 h post-vaccination. pr

2022-09-13

Systemic reaction (other): Taking daily 190 mg allegra due to previously reported symptoms including rash
Healthcare visit (other): Notification to allergist and primary care. Tried reporting to Moderna but no one to take the xall

Release 12 — day 7, dose 5

2022-09-18

Systemic reaction (other): Taking fexofenadine daily sue to rash, itching, swelling. Much milderBut not gone yet. Reaction at injection sute still visible , pain, swelling, redness

Release 12 — day 21, dose 5

2022-10-02

Symptoms: Joints aches and fatigue

Release 12 — day 28, dose 5

2022-10-09

Symptoms: Joints pau. And pain in upper arm muscke ( vaccination site)

Release 12 — day 35, dose 5

2022-10-17

Symptoms: Joints paun

Release 12 — day 42, dose 5

2022-10-23

Symptoms: Arhtralgias

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOMedical counselling · · ✓
SDAntinuclear antibody positive · · ✓
SDArthralgia · · ✓
SDFatigue · · ✓
SDInjection site pain · · ✓
SDIrritable bowel syndrome · · ✓
SDJoint instability · · ✓
SDLight chain analysis increased · · ✓
SDMuscular weakness · · ✓
SDOedema peripheral · · ✓
SDPruritus · · ✓
SDUrticaria · · ✓
SROAdverse reaction · · ✓
SROHeadache · · ✓
SROInjection site erythema · · ✓
SROInjection site pain · · ✓
SROInjection site swelling · · ✓
SROPruritus · · ✓
SROPyrexia · · ✓
SRORash · · ✓
SROSelf-medication · · ✓
SROSkin oedema · · ✓
SROSwelling · · ✓
SROVisual field defect · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release